DDH need two new program support

Ended Awarded Last action

Contract number
75F40123F19273
Awardee
Awarding agency
Obligated
$160,380

Award facts

Contract value 100% obligated
$160,379.72 Current and potential, with all options
Completion date 100% complete
  • Current, with exercised options
  • Potential, with all options
Set-aside
Competitive 8(a)
Competition
Full and Open Competition Multiple Award, Fair Opportunity
Pricing
Labor Hours
Place of performance
Silver Spring, MD 20993, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Close Out P00003 -$1,175
Other Administrative Action P00002 -$22,492
Other Administrative Action P00001 $10,267
Original award $173,779

About this award

The FDA issued a BPA call to Brillient Corporation valued at $160,379.72 under the Professional and Technical Services Blanket Purchase Agreement, awarded April 14, 2023, with an ultimate completion date of August 25, 2026. The call is set aside as Competitive 8(a). Work is performed in Silver Spring, Maryland. The call is priced on a labor-hours basis and supports program staffing needs at the FDA.

Quick answers

Who was awarded contract 75F40123F19273?

75F40123F19273 was awarded to Brillient Corporation by Food and Drug Administration (Department of Health and Human Services) on April 14, 2023.

How much is contract 75F40123F19273 worth?

The government has obligated $160,380 on 75F40123F19273.

Is contract 75F40123F19273 an order under another contract?

Yes. 75F40123F19273 is a BPA call under GS00F012BA-HHSF223201810005B, a blanket purchase agreement, on Multiple Award Schedule (MAS).

Was contract 75F40123F19273 competed?

The extent of competition for 75F40123F19273 was full and open competition. It was set aside: Competitive 8(a).

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award